Clinical Trial Update: BCG Re-vaccination for Primary Tuberculosis Prophylaxis in the Prison Population [Phase 4]

View source ↗

Summary

Phase 4 trial on BCG re-vaccination for latent tuberculosis prophylaxis in prisoners was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: Federal University of Mato Grosso | Conditions: Latent Tuberculosis | Phase 4 | Status: WITHDRAWN